Log In
BCIQ
Print this Print this
 

GL-0817

  Manage Alerts
Collapse Summary General Information
Company Gliknik Inc.
DescriptionVaccine against melanoma-associated antigen A3 (MAGEA3)
Molecular Target Melanoma-associated antigen A3 (MAGEA3)
Mechanism of ActionImmune modulation; Vaccine
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today